Medication info
Metmin Tablet 500 mg (Metformin Hydrochloride)

Metmin Tablet 500 mg (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Poongrim Pharm Co., Ltd.
Appearance
White round film-coated tablet
Packaging
500 tablets/bottle
Approval status
Active

MFDS item code 201402467 · Approved 2014.05.30 · Insurance code 649001140

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on drug efficacy and tolerability, and should not exceed the recommended maximum daily dose. - Treatment with this drug must be initiated at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose required for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; the maximum daily dose is 2550mg. - At initiation and during dose adjustment, measure fasting blood glucose to assess the response to treatment and identify the minimum effective dose. Measure blood glycated hemoglobin approximately every 3 months. - The goal of treatment with this drug, whether administered as monotherapy or concomitantly with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. - In general, if blood glucose is temporarily uncontrolled in patients previously controlled by diet alone, short-term administration of this drug may be sufficient to achieve an adequate effect. Patients with renal impairment This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Monitor renal function closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, discontinue this drug immediately.
Child dose
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500mg once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Ingredients

Manufacturer
Poongrim Pharm Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes
View approved original text

This medication is used for patients with Type 2 diabetes who have difficulty controlling their blood sugar with diet and exercise alone, particularly in overweight adults and children and adolescents over the age of 10. In adults, it can be used alone or in combination with other oral hypoglycemic agents or insulin, and it can also effectively control blood sugar when used alone or in combination with insulin for children and adolescents. This medication helps manage blood sugar and improves diabetes treatment.

How to take

Adult dose

The dose should be determined individually based on drug efficacy and tolerability, and should not exceed the recommended maximum daily dose. - Treatment with this drug must be initiated at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose required for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; the maximum daily dose is 2550mg. - At initiation and during dose adjustment, measure fasting blood glucose to assess the response to treatment and identify the minimum effective dose. Measure blood glycated hemoglobin approximately every 3 months. - The goal of treatment with this drug, whether administered as monotherapy or concomitantly with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. - In general, if blood glucose is temporarily uncontrolled in patients previously controlled by diet alone, short-term administration of this drug may be sufficient to achieve an adequate effect. Patients with renal impairment This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Monitor renal function closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, discontinue this drug immediately.

Child dose

Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500mg once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution should be exercised before taking it. Patients with moderate to severe kidney dysfunction, acute infections, or dehydration should avoid taking this medication. Patients with acute heart failure or myocardial infarction, as well as those undergoing examinations using iodinated contrast agents, should not use this medication. Those with hypersensitivity to this drug or with Type 1 diabetes or diabetic ketoacidosis should also refrain from using it. Patients with severe infections or trauma should stop taking this medication until the oral intake is recovered and kidney function is normal. Patients scheduled for surgery should stop this medication 48 hours before the procedure and should restart it once kidney function is confirmed to be normal. Patients with very poor nutritional status, liver dysfunction, severe pulmonary disease, or those who consume excessive alcohol should also be cautious about taking this medication. During pregnancy, this medication should be avoided if there is a risk of placental insufficiency, pre-eclampsia, or intrauterine growth restriction. There is a risk of lactic acidosis and hypoglycemia when meals are irregular, intense exercise is performed, or interacting medications are taken, so caution should be exercised. Lactic acidosis is rare but can be a very serious side effect; symptoms such as fatigue, muscle pain, difficulty breathing, and abdominal pain should be reported to healthcare professionals immediately. This medication may commonly cause gastrointestinal disorders, diarrhea, nausea, and vomiting during initial treatment, which can be alleviated by taking it with meals or by gradually increasing the dose. Skin rashes, blood abnormalities, liver function abnormalities, and rarely hypoglycemia can occur, so if there are any abnormal symptoms, one should consult a physician immediately. Renal function should be monitored regularly, especially in elderly patients or those with reduced kidney function, who require more caution. This medication has an increased risk of lactic acidosis when taken with alcohol, so alcohol consumption should be avoided. Additionally, this medication can affect blood sugar control when taken with other hypoglycemic agents, so it should be taken according to medical advice. During pregnancy, consider the effects on the fetus; use only if necessary, and during breastfeeding, this medication is excreted in breast milk, so the decision to breastfeed should be made carefully. In cases of overdose, blood dialysis may be required, so the dosage must be strictly adhered to. This medication should be kept out of reach of children and not transferred to other containers.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
  • unpleasant metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • abnormal liver function
  • severe delayed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is well-ventilated, at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.